The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Synbiotic modulation of gut flora: Effect on minimal hepatic encephalopathy in patients with cirrhosis
Open accessAbstract
Minimal hepatic encephalopathy (MHE) is an important disorder that may seriously impair daily functioning and quality of life in patients with cirrhosis. Treatment with lactulose is of benefit. The possible role of synbiotics (probiotics and fermentable fiber) has not been assessed. We screened 97 consecutive cirrhotic patients without overt hepatic encephalopathy for MHE using the number connection test and measurement of brainstem auditory evoked potentials. MHE, defined by abnormality on at least one test modality, was present in 58 (60%) patients. Fifty-five of these patients with MHE were randomized to receive a synbiotic preparation (n = 20), fermentable fiber alone (n = 20), or placebo (n = 15) for 30 days. Cirrhotic patients with MHE were found to have substantial derangements in the gut microecology, with significant fecal overgrowth of potentially pathogenic Escherichia coli and Staphylococcal species. Synbiotic treatment significantly increased the fecal content of non-urease-producing Lactobacillus species at the expense of these other bacterial species. Such modulation of the gut flora was associated with a significant reduction in blood ammonia levels and reversal of MHE in 50% of patients. Synbiotic treatment was also associated with a significant reduction in endotoxemia. The Child-Turcotte-Pugh functional class improved in nearly 50% of cases. Treatment with fermentable fiber alone was also of benefit in a substantial proportion of patients. In conclusion, treatment with synbiotics or fermentable fiber is an alternative to lactulose for the management of MHE in patients with cirrhosis. (Hepatology 2004;39:1441-1449.)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Transection of the oesophagus for bleeding oesophageal varices
Pugh, R. N. H., Murray-Lyon, I. M., Dawson, J. L., Pietroni, M. C., & Williams, R. (1973) · Journal of British Surgery · doi:10.1002/bjs.1800600817 · Cited by 7,941
Li, Z., Yang, S., Lin, H., Huang, J., Watkins, P. A., Moser, A. B., DeSimone, C., Song, X.-Y., & Diehl, A. M. (2003) · Hepatology · doi:10.1053/jhep.2003.50048 · Cited by 930
Neuropsychological characterization of hepatic encephalopathy
Weissenborn, K., Ennen, J. C., Schomerus, H., Rückert, N., & Hecker, H. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00026-5 · Cited by 796
Treatment of Hepatic Encephalopathy
Riordan, S. M., & Williams, R. (1997) · New England Journal of Medicine · doi:10.1056/nejm199708143370707 · Cited by 489
Self-citationLactobacillus Feeding Reduces Endotoxemia and Severity of Experimental Alcoholic Liver (Disease)
Nanji, A. A., Khettry, U., & Sadrzadeh, S. M. H. (1994) · Experimental Biology and Medicine · doi:10.3181/00379727-205-43703 · Cited by 436
Cerebral Ammonia Metabolism in Patients with Severe Liver Disease and Minimal Hepatic Encephalopathy
Lockwood, A. H., Yap, E. W. H., & Wong, W.-H. (1991) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1991.67 · Cited by 330
Prevalence and natural history of subclinical hepatic encephalopathy in cirrhosis
Das, A., Dhiman, R. K., Saraswat, V. A., Verma, M., & Naik, S. R. (2001) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.2001.02487.x · Cited by 298
Amodio, P., Del Piccolo, F., Marchetti, P., Angeli, P., Iemmolo, R., Caregaro, L., Merkel, C., Gerunda, G., & Gatta, A. (1999) · Hepatology · doi:10.1002/hep.510290619 · Cited by 251
Screening of subclinical hepatic encephalopathy
Groeneweg, M., Moerland, W., Quero, J. C., Hop, W. C. J., Krabbe, P. F., & Schalm, S. W. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80243-3 · Cited by 209
Quality of Life in Cirrhotics with Minimal Hepatic Encephalopathy
Schomerus, H., & Hamster, W. (2001) · Metabolic Brain Disease · doi:10.1023/a:1011610427843 · Cited by 206
Cited by
Changes of Intestinal Functions in Liver Cirrhosis
Fukui, H., & Wiest, R. (2016) · Inflammatory Intestinal Diseases · doi:10.1159/000444436 · Cited by 6,808
Gut microbiota in health and disease
Sekirov, I., Russell, S. L., Antunes, L. C. M., & Finlay, B. B. (2010) · Physiological Reviews · doi:10.1152/physrev.00045.2009 · Cited by 4,182
Characterization of fecal microbial communities in patients with liver cirrhosis
Chen, Y., Yang, F., Lu, H., Wang, B., Chen, Y., Lei, D., Wang, Y., Zhu, B., & Li, L. (2011) · Hepatology · doi:10.1002/hep.24423 · Cited by 1,038
The Human Microbiota in Health and Disease
Wang, B., Yao, M., Lv, L., Ling, Z., & Li, L. (2017) · Engineering · doi:10.1016/j.eng.2017.01.008 · Cited by 850
Modulation of the fecal bile acid profile by gut microbiota in cirrhosis
Kakiyama, G., Pandak, W. M., Gillevet, P. M., Hylemon, P. B., Heuman, D. M., Daita, K., Takei, H., Muto, A., Nittono, H., Ridlon, J. M., et al. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.01.003 · Cited by 781
Colonic microbiome is altered in alcoholism
Mutlu, E. A., Gillevet, P. M., Rangwala, H., Sikaroodi, M., Naqvi, A., Engen, P. A., Kwasny, M., Lau, C. K., & Keshavarzian, A. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00380.2011 · Cited by 775
Toll‐like receptors and adaptor molecules in liver disease: Update†
Seki, E., & Brenner, D. A. (2008) · Hepatology · doi:10.1002/hep.22306 · Cited by 722
The Gut Microbiome and the Brain
Galland, L. (2014) · Journal of Medicinal Food · doi:10.1089/jmf.2014.7000 · Cited by 648
Prasad, S., Dhiman, R. K., Duseja, A., Chawla, Y. K., Sharma, A., & Agarwal, R. (2007) · Hepatology · doi:10.1002/hep.21533 · Cited by 601
Linkage of gut microbiome with cognition in hepatic encephalopathy
Bajaj, J. S., Ridlon, J. M., Hylemon, P. B., Thacker, L. R., Heuman, D. M., Smith, S., Sikaroodi, M., & Gillevet, P. M. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00190.2011 · Cited by 547
Kirpich, I. A., Solovieva, N. V., Leikhter, S. N., Shidakova, N. A., Lebedeva, O. V., Sidorov, P. I., Bazhukova, T. A., Soloviev, A. G., Barve, S. S., McClain, C. J., et al. (2008) · Alcohol · doi:10.1016/j.alcohol.2008.08.006 · Cited by 488
Rayes, N., Seehofer, D., Theruvath, T., Schiller, R. A., Langrehr, J. M., Jonas, S., Bengmark, S., & Neuhaus, P. (2005) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2004.00649.x · Cited by 478
Self-citationBifidobacterium longum with Fructo-Oligosaccharides in Patients with Non Alcoholic Steatohepatitis
Malaguarnera, M., Vacante, M., Antic, T., Giordano, M., Chisari, G., Acquaviva, R., Mastrojeni, S., Malaguarnera, G., Mistretta, A., Li Volti, G., et al. (2012) · Digestive Diseases and Sciences · doi:10.1007/s10620-011-1887-4 · Cited by 455
Gut Microbiota and Inflammation
Hakansson, A., & Molin, G. (2011) · Nutrients · doi:10.3390/nu3060637 · Cited by 455
The Gastrointestinal Microbiome: Alcohol Effects on the Composition of Intestinal Microbiota
Engen, P. (2015) · Alcohol Research: Current Reviews · doi:10.35946/arcr.v37.2.07 · Cited by 436
Amodio, P., Bemeur, C., Butterworth, R., Cordoba, J., Kato, A., Montagnese, S., Uribe, M., Vilstrup, H., & Morgan, M. Y. (2013) · Hepatology · doi:10.1002/hep.26370 · Cited by 420
Targeting the gut-liver axis in liver disease
Wiest, R., Albillos, A., Trauner, M., Bajaj, J. S., & Jalan, R. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.05.007 · Cited by 419
Kurtz, C. B., Millet, Y. A., Puurunen, M. K., Perreault, M., Charbonneau, M. R., Isabella, V. M., Kotula, J. W., Antipov, E., Dagon, Y., Denney, W. S., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aau7975 · Cited by 399
Immune Dysfunction and Infections in Patients With Cirrhosis
Bonnel, A. R., Bunchorntavakul, C., & Reddy, K. R. (2011) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2011.02.031 · Cited by 396
Forsyth, C. B., Farhadi, A., Jakate, S. M., Tang, Y., Shaikh, M., & Keshavarzian, A. (2009) · Alcohol · doi:10.1016/j.alcohol.2008.12.009 · Cited by 394
Spontaneous bacterial peritonitis: recent guidelines and beyond
Wiest, R., Krag, A., & Gerbes, A. (2012) · Gut · doi:10.1136/gutjnl-2011-300779 · Cited by 386
Alcohol and Gut-Derived Inflammation
Bishehsari, F. (2017) · Alcohol Research: Current Reviews · doi:10.35946/arcr.v38.2.02 · Cited by 364
Portal Hypertension and Its Complications
Sanyal, A. J., Bosch, J., Blei, A., & Arroyo, V. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.03.007 · Cited by 358
Malla, M. A., Dubey, A., Kumar, A., Yadav, S., Hashem, A., & Abd_Allah, E. F. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02868 · Cited by 345
Cheung, K., Lee, S. S., & Raman, M. (2012) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2011.08.016 · Cited by 343
Dhiman, R. K., Rana, B., Agrawal, S., Garg, A., Chopra, M., Thumburu, K. K., Khattri, A., Malhotra, S., Duseja, A., & Chawla, Y. K. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.08.031 · Cited by 339
Snydman, D. R. (2008) · Clinical Infectious Diseases · doi:10.1086/523331 · Cited by 336
Toll-like receptors as targets in chronic liver diseases
Mencin, A., Kluwe, J., & Schwabe, R. F. (2009) · Gut · doi:10.1136/gut.2008.156307 · Cited by 329
Sharma, B. C., Sharma, P., Agrawal, A., & Sarin, S. K. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.05.056 · Cited by 325
Pathogenesis of Hepatic Encephalopathy: Role of Ammonia and Systemic Inflammation
Aldridge, D. R., Tranah, E. J., & Shawcross, D. L. (2015) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2014.06.004 · Cited by 313
Synbiotics in Health and Disease
Kolida, S., & Gibson, G. R. (2011) · Annual Review of Food Science and Technology · doi:10.1146/annurev-food-022510-133739 · Cited by 309
Liu, Z., Qin, H., Yang, Z., Xia, Y., Liu, W., Yang, J., Jiang, Y., Zhang, H., Yang, Z., Wang, Y., et al. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2010.04492.x · Cited by 300
Lactobacillus rhamnosus GG protects against non-alcoholic fatty liver disease in mice
Ritze, Y., Bárdos, G., Claus, A., Ehrmann, V., Bergheim, I., Schwiertz, A., & Bischoff, S. C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0080169 · Cited by 292
Stadlbauer, V., Mookerjee, R. P., Hodges, S., Wright, G. A. K., Davies, N. A., & Jalan, R. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.02.015 · Cited by 288
The Role of Gut-Derived Lipopolysaccharides and the Intestinal Barrier in Fatty Liver Diseases
An, L., Wirth, U., Koch, D., Schirren, M., Drefs, M., Koliogiannis, D., Nieß, H., Andrassy, J., Guba, M., Bazhin, A. V., et al. (2022) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-021-05188-7 · Cited by 284
Probiotics in Medicine: A Long Debate
Stavropoulou, E., & Bezirtzoglou, E. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02192 · Cited by 282
Alcoholic Liver Disease: The Gut Microbiome and Liver Cross Talk
Hartmann, P., Seebauer, C. T., & Schnabl, B. (2015) · Alcoholism: Clinical and Experimental Research · doi:10.1111/acer.12704 · Cited by 282
Probiotic Yogurt for the Treatment of Minimal Hepatic Encephalopathy
Bajaj, J. S., Saeian, K., Christensen, K. M., Hafeezullah, M., Varma, R. R., Franco, J., Pleuss, J. A., Krakower, G., Hoffmann, R. G., & Binion, D. G. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.01861.x · Cited by 269
Borrelli, A., Bonelli, P., Tuccillo, F. M., Goldfine, I. D., Evans, J. L., Buonaguro, F. M., & Mancini, A. (2018) · Redox Biology · doi:10.1016/j.redox.2018.01.009 · Cited by 266
Role of ammonia and inflammation in minimal hepatic encephalopathy
Shawcross, D. L., Wright, G., Olde Damink, S. W. M., & Jalan, R. (2007) · Metabolic Brain Disease · doi:10.1007/s11011-006-9042-1 · Cited by 265
Gut microbiota, immune development and function
Bengmark, S. (2013) · Pharmacological Research · doi:10.1016/j.phrs.2012.09.002 · Cited by 262
Self-citationAltered gut flora and environment in patients with severe SIRS
Shimizu, K., Ogura, H., Goto, M., Asahara, T., Nomoto, K., Morotomi, M., Yoshiya, K., Matsushima, A., Sumi, Y., Kuwagata, Y., et al. (2006) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/01.ta.0000197374.99755.fe · Cited by 257
Probiotics, Prebiotics, and Synbiotics: Gut and Beyond
Vyas, U., & Ranganathan, N. (2012) · Gastroenterology Research and Practice · doi:10.1155/2012/872716 · Cited by 256
Microbiome as a therapeutic target in alcohol-related liver disease
Sarin, S. K., Pande, A., & Schnabl, B. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2018.10.019 · Cited by 253
Probiotics Prevent Hepatic Encephalopathy in Patients with Cirrhosis: A Randomized Controlled Trial
Lunia, M. K., Sharma, B. C., Sharma, P., Sachdeva, S., & Srivastava, S. (2014) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.11.006 · Cited by 218
Shimizu, K., Ogura, H., Hamasaki, T., Goto, M., Tasaki, O., Asahara, T., Nomoto, K., Morotomi, M., Matsushima, A., Kuwagata, Y., et al. (2011) · Digestive Diseases and Sciences · doi:10.1007/s10620-010-1418-8 · Cited by 213
Gupta, A., Dhiman, R. K., Kumari, S., Rana, S., Agarwal, R., Duseja, A., & Chawla, Y. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.05.017 · Cited by 202
Gut microbiota and probiotics in chronic liver diseases
Cesaro, C., Tiso, A., Del Prete, A., Cariello, R., Tuccillo, C., Cotticelli, G., del Vecchio Blanco, C., & Loguercio, C. (2011) · Digestive and Liver Disease · doi:10.1016/j.dld.2010.10.015 · Cited by 182
Toll-like Receptor 4 and Hepatic Fibrogenesis
Pradere, J.-P., Troeger, J., Dapito, D., Mencin, A., & Schwabe, R. (2010) · Seminars in Liver Disease · doi:10.1055/s-0030-1255353 · Cited by 158
Small‐intestinal bacterial overgrowth in cirrhosis is related to the severity of liver disease
PANDE, C., KUMAR, A., & SARIN, S. K. (2009) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2009.03994.x · Cited by 152
Han, S. H., Suk, K. T., Kim, D. J., Kim, M. Y., Baik, S. K., Kim, Y. D., Cheon, G. J., Choi, D. H., Ham, Y. L., Shin, D. H., et al. (2015) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000000458 · Cited by 149
The gut microbiota and the liver. Pathophysiological and clinical implications
Quigley, E. M. M., Stanton, C., & Murphy, E. F. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2012.11.023 · Cited by 133
Gastrointestinal dysfunction in liver cirrhosis
Kalaitzakis, E. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i40.14686 · Cited by 127
The microbiota and its metabolites in colonic mucosal health and cancer risk
Vipperla, K., & O'Keefe, S. J. (2012) · Nutrition in Clinical Practice · doi:10.1177/0884533612452012 · Cited by 116
Probiotics in primary sclerosing cholangitis: a randomized placebo-controlled crossover pilot study
Vleggaar, F. P., Monkelbaan, J. F., & van Erpecum, K. J. (2008) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e3282f5197e · Cited by 110
Probiotics are helpful in hepatic encephalopathy: A meta-analysis of randomized trials
Saab, S., Suraweera, D., Au, J., Saab, E. G., Alper, T. S., & Tong, M. J. (2016) · Liver International · doi:10.1111/liv.13005 · Cited by 86
Serum endotoxin and inflammatory mediators in patients with cirrhosis and hepatic encephalopathy
Jain, L., Sharma, B. C., Sharma, P., Srivastava, S., Agrawal, A., & Sarin, S. K. (2012) · Digestive and Liver Disease · doi:10.1016/j.dld.2012.07.002 · Cited by 71
Visschers, R. G. J., Luyer, M. D., Schaap, F. G., Olde Damink, S. W. M., & Soeters, P. B. (2013) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e32836410a4 · Cited by 60
Lata, J. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i24.2890 · Cited by 58
Advances in Gut Microbiota of Viral Hepatitis Cirrhosis
Wang, Y., Pan, C. Q., & Xing, H. (2019) · BioMed Research International · doi:10.1155/2019/9726786 · Cited by 52
Liu, P. C., Yan, Y. K., Ma, Y. J., Wang, X. W., Geng, J., Wang, M. C., Wei, F. X., Zhang, Y. W., Xu, X. D., & Zhang, Y. C. (2017) · Gastroenterology Research and Practice · doi:10.1155/2017/6029075 · Cited by 49
The Human Gut Microbiome in Liver Diseases
Davis, B., & Bajaj, J. (2017) · Seminars in Liver Disease · doi:10.1055/s-0037-1602763 · Cited by 34
Hepatic Encephalopathy Involves Interactions Among the Microbiota, Gut, Brain
Victor, D. W., & Quigley, E. M. M. (2014) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.01.022 · Cited by 12
Sharma, B. C., Maharshi, S., Sachdeva, S., Mahajan, B., Sharma, A., Bara, S., Srivastava, S., Kumar, A., Dalal, A., & Sonika, U. (2023) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.16266 · Cited by 11
Metadata
- Authors
- Liu, Q., Duan, Z. P., Ha, D. K., Bengmark, S., Kurtovic, J., & Riordan, S. M.
- Venue
- Hepatology
- Published
- 2004-05
- Volume
- 39
- Issue
- 5
- Pages
- 1441-1449
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2068894782
- Cited by
- 638
- References
- 28
- FWCI
- 16.06
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.